Integrated Diagnostics Holdings plc (IDGXF)
USD 0.32
(13.78%)
USD 0.32
(13.78%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 510.3 Million EGP | -5.69% |
| 2022 | 541.11 Million EGP | -61.69% |
| 2021 | 1.41 Billion EGP | 137.81% |
| 2020 | 594.01 Million EGP | 16.26% |
| 2019 | 510.93 Million EGP | 1.76% |
| 2018 | 502.09 Million EGP | 34.24% |
| 2017 | 374.02 Million EGP | 43.63% |
| 2016 | 260.39 Million EGP | 79.74% |
| 2015 | 144.87 Million EGP | 9.12% |
| 2014 | 132.76 Million EGP | 113.82% |
| 2013 | 62.09 Million EGP | 151.99% |
| 2012 | 24.64 Million EGP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 417.58 Million EGP | 283.37% |
| 2024 Q2 | 112.98 Million EGP | -72.94% |
| 2023 Q3 | 177.78 Million EGP | 250.8% |
| 2023 Q4 | 108.92 Million EGP | -38.73% |
| 2023 FY | 510.3 Million EGP | -5.69% |
| 2023 Q1 | 172.9 Million EGP | 26.14% |
| 2023 Q2 | 50.68 Million EGP | -70.69% |
| 2022 Q2 | 125.61 Million EGP | -57.65% |
| 2022 Q1 | 296.6 Million EGP | -4.91% |
| 2022 Q4 | 137.07 Million EGP | 484.55% |
| 2022 Q3 | -35.64 Million EGP | -128.38% |
| 2022 FY | 541.11 Million EGP | -61.69% |
| 2021 Q3 | 454.23 Million EGP | 41.77% |
| 2021 Q4 | 311.93 Million EGP | -31.33% |
| 2021 FY | 1.41 Billion EGP | 137.81% |
| 2021 Q2 | 320.41 Million EGP | -1.72% |
| 2021 Q1 | 326.03 Million EGP | 47.61% |
| 2020 Q4 | 220.87 Million EGP | 13.64% |
| 2020 FY | 594.01 Million EGP | 16.26% |
| 2020 Q3 | 194.37 Million EGP | 159.66% |
| 2020 Q2 | 74.85 Million EGP | -27.96% |
| 2020 Q1 | 103.91 Million EGP | -30.69% |
| 2019 Q2 | 99.87 Million EGP | -19.46% |
| 2019 Q1 | 124 Million EGP | -15.12% |
| 2019 FY | 510.93 Million EGP | 1.76% |
| 2019 Q4 | 149.93 Million EGP | 9.34% |
| 2019 Q3 | 137.12 Million EGP | 37.3% |
| 2018 FY | 502.09 Million EGP | 34.24% |
| 2018 Q2 | 108.23 Million EGP | 0.0% |
| 2018 Q4 | 146.09 Million EGP | 4.7% |
| 2018 Q1 | 108.23 Million EGP | 18.91% |
| 2018 Q3 | 139.53 Million EGP | 28.93% |
| 2017 Q2 | 77.67 Million EGP | 0.0% |
| 2017 FY | 374.02 Million EGP | 43.63% |
| 2017 Q1 | 77.67 Million EGP | 29.46% |
| 2017 Q3 | 127.65 Million EGP | 64.35% |
| 2017 Q4 | 91.02 Million EGP | -28.7% |
| 2016 Q2 | 61.65 Million EGP | 0.0% |
| 2016 FY | 260.39 Million EGP | 79.74% |
| 2016 Q4 | 59.99 Million EGP | -22.16% |
| 2016 Q3 | 77.08 Million EGP | 25.01% |
| 2016 Q1 | 61.65 Million EGP | 30.99% |
| 2015 Q2 | 8.45 Million EGP | 0.0% |
| 2015 Q1 | 8.45 Million EGP | -76.49% |
| 2015 FY | 144.87 Million EGP | 9.12% |
| 2015 Q4 | 47.07 Million EGP | -41.81% |
| 2015 Q3 | 80.89 Million EGP | 857.33% |
| 2014 Q4 | 35.93 Million EGP | 1.46% |
| 2014 Q3 | 35.42 Million EGP | 25.25% |
| 2014 Q2 | 28.28 Million EGP | 0.0% |
| 2014 Q1 | 28.28 Million EGP | 232.92% |
| 2014 FY | 132.76 Million EGP | 113.82% |
| 2013 FY | 62.09 Million EGP | 151.99% |
| 2013 Q2 | 17.19 Million EGP | 0.0% |
| 2013 Q3 | 17.19 Million EGP | 0.0% |
| 2013 Q4 | 8.49 Million EGP | -50.6% |
| 2013 Q1 | 17.19 Million EGP | 0.0% |
| 2012 FY | 24.64 Million EGP | 0.0% |
| 2012 Q4 | 17.19 Million EGP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | 36291.773% |
| Arrayit Corporation | -3.31 Million USD | 15491.028% |
| Atlantic International Corp. | -5.62 Million USD | 9167.894% |
| Biocept, Inc. | -32.08 Million USD | 1690.376% |
| Bioqual, Inc. | 483.48 Thousand USD | -105447.891% |
| CardioGenics Holdings Inc | -1.91 Million USD | 26729.317% |
| DermTech, Inc. | -100.88 Million USD | 605.812% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 74.798% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 2463.123% |
| iMD Companies, Inc. | -200.63 Thousand USD | 254443.189% |
| IDenta Corp. | 14.64 Thousand USD | -3484630.948% |
| Interpace Biosciences, Inc. | 802 Thousand USD | -63528.928% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | -1318889.894% |
| InVitro International | 1553.00 USD | -32859140.18% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 6039.292% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 878238.767% |
| Medical Imaging Corp. | -3.02 Million USD | 16980.581% |
| NovelStem International Corp. | -4.18 Million USD | 12286.946% |
| Optigenex Inc. | -2.89 Million USD | 17710.292% |
| PharmChem, Inc. | 845.1 Thousand USD | -60283.717% |
| Proteome Sciences plc | -2.44 Million USD | 20988.416% |
| Response Genetics, Inc | -20.18 Million USD | 2628.26% |
| Rennova Health, Inc. | -3.29 Million USD | 15596.37% |
| RushNet, Inc. | -607.02 Thousand USD | 84165.974% |
| ScreenPro Security Inc. | -2.24 Million USD | 22792.613% |
| Stella Diagnostics Inc. | -5.7 Million USD | 9041.05% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 4570.323% |
| Todos Medical Ltd. | -24.99 Million USD | 2141.706% |